ConductScience.org, home

Paper42945342PubMed

MARK3 promotes host antiviral defense by driving GEF-H1-mediated TBK1 activation.

Qi X and 17 others. PLoS Pathog, 2026.

Cite this record

ConductScience Library. MARK3 promotes host antiviral defense by driving GEF-H1-mediated TBK1 activation. Papers, record 42945342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42945342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MARK3 promotes host antiviral defense by driving GEF-H1-mediated TBK1 activation.
Journal
PLoS Pathog
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-29

Source PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qi XXingmei
2Zhu XXue
3Peng WWenbiao
4Hua LLuoxue
5Xie XXinru
6Si CChuncan
7Lan MMeimei
8Zhuang ZZifan
9Ding SSiyi
10Xu TTing
11Li JJunjie
12Zhang YYundi
13Song YYifan
14Yang YYiping
15Cheng YYixue
16Guo TTao
17Li LLinchao
18Wang KKezhenhttps://orcid.org/0000-0003-0530-7098

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein Serine-Threonine KinasesMajor topic
Immunity, InnateMajor topic
Rho Guanine Nucleotide Exchange FactorsMajor topic
Animals
Humans
Mice
Phosphorylation
Interferon Regulatory Factor-3
Signal Transduction
Interferon Type I

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133328453Genetic architecture of host proteins involved in SARS-CoV-2 infection.Nat Commun2020https://conductscience.org/library/papers/33328453PubMed
211741534C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1.Mol Cell2001https://conductscience.org/library/papers/11741534PubMed
324533944MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.Acta Neuropathol Commun2014https://conductscience.org/library/papers/24533944PubMed
418394899Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis?Trends Cell Biol2008https://conductscience.org/library/papers/18394899PubMed
532075101Microtubule-Mediated NLRP3 Inflammasome Activation Is Independent of Microtubule-Associated Innate Immune Factor GEF-H1 in Murine Macrophages.Int J Mol Sci2020https://conductscience.org/library/papers/32075101PubMed
619120477Innate immunity to virus infection.Immunol Rev2009https://conductscience.org/library/papers/19120477PubMed
735681428Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.Cells2022https://conductscience.org/library/papers/35681428PubMed
815827085PAK4 mediates morphological changes through the regulation of GEF-H1.J Cell Sci2005https://conductscience.org/library/papers/15827085PubMed
936113429Actin cytoskeleton remodeling primes RIG-I-like receptor activation.Cell2022https://conductscience.org/library/papers/36113429PubMed
1018287519GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA.Mol Biol Cell2008https://conductscience.org/library/papers/18287519PubMed
1136384137AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity.Mol Cell2022https://conductscience.org/library/papers/36384137PubMed
1214976552LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.EMBO J2004https://conductscience.org/library/papers/14976552PubMed
1326235147STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease.Cell Host Microbe2015https://conductscience.org/library/papers/26235147PubMed
1417488622GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases.Dev Cell2007https://conductscience.org/library/papers/17488622PubMed
1516125763Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.Cell2005https://conductscience.org/library/papers/16125763PubMed
1628783414Guanine nucleotide exchange factor -H1 promotes inflammatory cytokine production and intracellular mycobacterial elimination in macrophages.Cell Cycle2017https://conductscience.org/library/papers/28783414PubMed
1717483521Mechanisms of activation of interferon regulator factor 3: the role of C-terminal domain phosphorylation in IRF-3 dimerization and DNA binding.Nucleic Acids Res2007https://conductscience.org/library/papers/17483521PubMed
1811433294PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.Nat Cell Biol2001https://conductscience.org/library/papers/11433294PubMed
1917699722CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.Mol Cancer Ther2007https://conductscience.org/library/papers/17699722PubMed
2011912491Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton.Nat Cell Biol2002https://conductscience.org/library/papers/11912491PubMed

See all 41 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42945342

GET https://conductscience.org/api/papers/v1/42945342/references?page=2